UK's 25% US Drug Price Deal: A 'Problematic Precedent'
The UK's agreement to pay 25% more for new US medicines has sparked warnings it could set a dangerous precedent for Australia's Pharmaceutical Benefits Scheme. Experts fear global ripple effects.